Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Kimberly Keene M.D.
Professor
Close
E-mail
kkeene@uab.edu
Links
UAB Department of Radiation Oncology
Provider Directory
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Kimberly Keene M.D.
Professor
Positions
Scientist (C)
,
O'Neal Comprehensive Cancer Center
,
School of Medicine
Professor (P)
,
Radiation Oncology
,
School of Medicine
Scientist
,
Experimental Therapeutics
,
O'Neal Comprehensive Cancer Center
Scholar (C)
,
Center for Clinical and Translational Science (CCTS)
,
General Clinical Research Center
Publications
Research
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2022
Feasibility and Short-Term Toxicity of a Consecutively Delivered Five Fraction Stereotactic Body Radiation Therapy Regimen in Early-Stage Breast Cancer Patients Receiving Partial Breast Irradiation
.
Frontiers in Oncology
. 12.
2022
2022
Bloom where you are planted: Hemangioma or malignancy?
.
Pediatric Blood and Cancer
. 69.
2022
2021
Breast Stereotactic Body Radiation Therapy (SBRT) Reduces Organ at Risk Exposure, Treatment Time and Duration in Partial Breast Irradiation
2021
2021
Satisfaction and Regret With Decision Making in Older Women With Breast Cancer
2021
2021
The Opioid Crisis and Radiation Therapy: A Patient Survey to Identify Best Practices for Pain Management
2021
2020
Study protocol for a multisite randomised controlled trial of a rehabilitation intervention to reduce participation restrictions among female breast cancer survivors
.
BMJ Open
. 10.
2020
2019
Hypofractionated radiation in older women with breast cancer
2019
2018
Molecular determinants of post-mastectomy breast cancer recurrence
.
npj Breast Cancer
. 4.
2018
2018
Radiation therapy utilization in Medicare beneficiaries with early-stage breast cancer
.
Cancer
. 124:475-481.
2018
2017
Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans
.
PLoS One
. 12.
2017
2016
Adherence to the Choosing Wisely Campaign Recommendations for Radiation Treatment Duration in Breast Cancer: Analysis of Medicare Data at 12 Centers in the Southeastern United States.
2016
2016
Intensity Modulated Radiation Therapy in Breast Cancer: Analysis of Medicare Data at 12 Institutions.
2016
2015
Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone
.
Journal of Gastrointestinal Cancer
. 46:149-155.
2015
2015
PARP1 and phospho-p65 protein expression is increased in human HER2-positive breast cancers
.
Breast Cancer Research and Treatment
. 150:569-579.
2015
2015
Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non-resectable hepatocellular carcinoma tumours of ≥3 cm
2015
2014
Quantitative perfusion- and diffusion-weighted magnetic resonance imaging of gastrointestinal cancers treated with multikinase inhibitors: A pilot study
.
Gastrointestinal cancer research : GCR
. 7:75-81.
2014
2014
The Impact of Breast Irradiation and Concurrent Trastuzumab on the Development of Early Cardiac Events: a Dosimetric Analysis
2014
2013
Accelerated partial breast irradiation for early-stage breast cancer: Controversies and current indications for use
.
Current Treatment Options in Oncology
. 14:51-65.
2013
2011
An update on the dosimetric analysis of concurrent radiation therapy and trastuzumab on early cardiac events.
.
Journal of Clinical Oncology
. 29:121.
2011
2011
A phase i study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer
.
Cancer Chemotherapy and Pharmacology
. 67:891-897.
2011
2011
Dosimetric analysis of imaging changes following pulmonary stereotactic body radiation therapy
.
Journal of Medical Imaging and Radiation Oncology
. 55:90-96.
2011
2011
Accuracy of breast magnetic resonance imaging in predicting pathologic response in patients treated with neoadjuvant chemotherapy
.
Clinical Breast Cancer
. 11:312-319.
2011
2010
The importance and evolution of radiation dose in DCIS
.
Current Cancer Therapy Reviews
. 6:249-255.
2010
2010
Intensity-modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status.
.
Cancer
. 116:2645-2654.
2010
2010
Margin on Gross Tumor Volume and Risk of Local Recurrence in Head-and-Neck Cancer
2010
2009
EGFR FISH as a predictive factor for selection of patients with non-small cell lung cancer treated with cetuximab and chemotherapy
.
American Journal of Oncology Review
. 8.
2009
2008
An imrt technique to increase therapeutic ratio of breast irradiation in patients with early-stage left breast cancer: limiting second malignancies
.
Medical Dosimetry
. 33:71-77.
2008
2007
Is cetuximab active in patients with cisplatin-refractory squamous cell carcinoma of the head and neck?: Commentary
.
Nature Reviews Clinical Oncology
. 4:690-691.
2007
2007
A Dosimetric Comparison of Electronic Compensation, Conventional Intensity Modulated Radiotherapy, and Tomotherapy in Patients With Early-Stage Carcinoma of the Left Breast
2007
2005
Five-year results of a phase II trial of hyperfractionated radiotherapy and concurrent daily cisplatin chemotherapy for stage III non-small-cell lung cancer
2005
2005
Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma
2005
2002
Erratum: Angiotensin I-converting enzyme antisense gene therapy causes permanent antihypertensive effects in spontaneously hypertensive rats (Hypertension (2002) 35:2 (202-208))
.
Hypertension
. 40:566.
2002
Research
Principal Investigator On
Molecular Predictors of Post-Mastectomy Breast Cancer Loco-Regional Recurrence
awarded by
National Cancer Institute/NIH/DHHS
Private Grant
awarded by
Bayer HealthCare
Quantifying the Burden of Breast Cancer Decision Making in Older Women
awarded by
American Society of Clinical Oncology
Investigator On
A Phase II Study of Durvalumab (MEDI 4736) with Radiotherapy for the adjuvant treatment of Intermediate Risk Head and Neck Squamous Cell Carcinoma
awarded by
University of North Carolina at Chapel Hill
A Prospective Analysis of Surgery in Patients Presenting with Stage IV Breast Cancer - TBCRC 013 / UAB 0953
awarded by
Johns Hopkins University
ECOG-ACRIN Purchase Service Agreement
awarded by
Eastern Cooperative Oncology Group
ECOG-ACRIN Purchase Service Agreement
awarded by
Eastern Cooperative Oncology Group
Life after Breast Cancer Treatment: Racial Health Disparities and Chronic Pain in Breast Cancer Survivors
awarded by
National Cancer Institute/NIH/DHHS
Markers of Cardiotoxicity with Radiation Therapy in Breast Cancer
awarded by
University of Pennsylvania
Markers of Cardiotoxicity with Radiation Therapy in Breast Cancer-Fixed Price
awarded by
University of Pennsylvania
NRG Oncology Member Institution Clinical Trial Fixed Price Subaward Agreement
awarded by
NRG ONCOLOGY FOUNDATION
Neoadjuvant Trial of Lapatinib for the Treatment of Women With DCIS Breast Cancer
awarded by
UNIVERSITY OF TEXAS (M.D. ANDERSON CANCER CENTER)
Optimizing Functional Recovery of Breast Cancer Survivors
awarded by
DARTMOUTH-HITCHCOCK CLINIC
Optimizing Functional Recovery of Breast Cancer Survivors
awarded by
DARTMOUTH-HITCHCOCK CLINIC
Optimizing Functional Recovery of Breast Cancer Survivors
awarded by
MASSACHUSETTS GENERAL HOSPITAL
Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect
awarded by
University of Wisconsin-Madison
Pragmatic Phase III Randomized Trial of Proton vs. Photon Therapy for Patients with Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial
awarded by
University of Pennsylvania
Private Grant
awarded by
ELI LILLY AND COMPANY
Private Grant
awarded by
SUCAMPO PHARMACEUTICALS
Private Grant
awarded by
NEWLINK GENETICS, INC
Private Grant
awarded by
VARIAN MEDICAL SYSTEMS, INC.
Quantifying the Burden of Breast Cancer Decision Making in Older Women
awarded by
American Society of Clinical Oncology
RTOG Foundation Master Service Agreement for Participation in Foundation Research: RTOG 3501 Tryhard: A Phase II, Randomized, Double Blind, Placebo-Controlled Study of Lapatinib (Tykerb) for Non-HPV Locally Advanced Head and Neck Cancer with Concurrent Chemoradiation
awarded by
American College of Radiology
Targeting Signal Transduction Pathways for the Treatment and Prevention of Breast Cancer
awarded by
UNIVERSITY OF TEXAS (M.D. ANDERSON CANCER CENTER)
UAB NRG Oncology Master Institution Purchased Service Agreement
awarded by
NRG ONCOLOGY FOUNDATION
UAB NRG Oncology Member Institution Purchased Service Agreement
awarded by
NRG ONCOLOGY FOUNDATION
UAB NRG Oncology Member Institution Purchased Service Agreement
awarded by
NRG ONCOLOGY FOUNDATION
Background
Education And Training
University of Florida/Shands Hospital, Internship
University of Virginia Hospital, Residency
Doctor of Medicine in Radiation Oncology,
University of Florida
2001
Contact
Full Name
Kimberly
Keene